Dihydrocurcumin regulates glucose intake, moderates SREBP-1C/PPAR-α/pAKT expression, and decreases levels of triglycerides, oxidative stress, and insulin resistance (Yu et al., 2018). This evidence concerns the gene SREBF1 and Insulin resistance.